Signaling Pathways
-
A3446 GSK1265 CitationTarget: EZH2Summary: EZH2 inhibitor
-
A3543 LDE225 DiphosphateTarget: SmoothenedSummary: Smo antagonist
-
A3570 LY2090314Target: GSK-3Summary: Potent GSK-3 inhibitor
-
A3719 PF-670462Target: CK1Summary: CK1 ε/δ inhibitor
-
A3785 SalinomycinTarget: AntibioticSummary: Polyether ionophore antibiotic;anti-cancer
-
B2266 LDE225 (NVP-LDE225,Erismodegib)1 CitationTarget: SmoothenedSummary: Smoothened inhibitor,potent and selective
-
A8182 3-Deazaneplanocin A (DZNep) hydrochloride1 CitationTarget: EZH2Summary: SAHH and EZH2 inhibitor
-
A3011 CHIR-99021 (CT99021)2 CitationTarget: GSK-3Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
-
A1905 3-Deazaneplanocin,DZNep6 CitationTarget: HydrolaseSummary: S-adenosylhomocysteine and EZH2 inhibitor
-
A4351 PluriSIn #1 (NSC 14613)Target: Stearoyl-CoA 9-desaturase (SCD-1)Summary: SCD1 inhibitor